New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Burning Rock Biotech Limited
BNR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

65M

Medical - Diagnostics & Research

Next Earning date - 27 Mar 2025

65M

Medical - Diagnostics & Research

Next Earning date - 27 Mar 2025

6.50USD

Shape-0.47 ( -6.74%)
sun-fogPre-market 5.17$arrow-left-down-1.33 (-20.54%)
Market Closed (as of Feb 05, 21:00 EDT)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-85%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

28%

Quote Panel

Shape
Updated February 6, 2025
1W -2.69 % 1M -7.93 % 3M 80.56 % 1Y -23.80 %

Key Metrics

Shape
  • Market Cap

    64.77M


  • Shares Outstanding

    9.97M


  • Share in Float

    9.94M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    6.5


  • Average Volume

    12011


  • Beta

    0.145


  • Range

    2.62-8.99


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.brbiotech.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

BNR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape831%

2025-Revenue

$27.05

Shape-682%

2025-EPS

$1B

Shape-2500%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-3.10
vs -2.50

Q4.22

arrow
arrow

N/A

-3.10
vs -3.80

Q1.23

arrow
arrow

N/A

-2.60
vs -3.90

Q2.23

arrow
arrow

N/A

-1.80
vs -3.70

Q3.23

arrow
arrow

N/A

-2.30
vs -3.10

Q4.23

arrow
arrow

N/A

-2.20
vs -3.10

Q1.24

arrow
arrow

N/A

-0.16
vs -2.60

Q2.24

arrow
arrow

N/A

-0.14
vs -1.80

Q3.24

arrow
arrow

N/A

-0.50
vs -2.30

Q4.24

arrow
arrow

N/A

-10.19
vs -2.20

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+22%

154.6M  vs 126.6M

Q4.22

arrow
arrow

-3%

142.2M  vs 147.3M

Q1.23

arrow
arrow

+5%

142.5M  vs 135.5M

Q2.23

arrow
arrow

+12%

146.3M  vs 130.8M

Q3.23

arrow
arrow

-17%

127.6M  vs 154.6M

Q4.23

arrow
arrow

-15%

121.1M  vs 142.2M

Q1.24

arrow
arrow

-12%

125.6M  vs 142.5M

Q2.24

arrow
arrow

-7%

135.5M  vs 146.3M

Q3.24

arrow
arrow

+1%

128.6M  vs 127.6M

Q4.24

arrow
arrow

+9%

131.5M  vs 121.1M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-19%

-0.19
vs -0.17

Q1.23

arrow
arrow

-18%

-0.18
vs -0.19

Q2.23

arrow
arrow

-14%

-0.14
vs -0.18

Q3.23

arrow
arrow

-20%

-0.20
vs -0.14

Q4.23

arrow
arrow

-21%

-0.21
vs -0.20

Q1.24

arrow
arrow

-17%

-0.17
vs -0.21

Q2.24

arrow
arrow

-16%

-0.16
vs -0.17

Q3.24

arrow
arrow

-6%

-0.06
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

40

40
vs 48

-17%

Q1.23

arrow
arrow

32

32
vs 40

-20%

Q2.23

arrow
arrow

31

31
vs 32

-3%

Q3.23

arrow
arrow

27

27
vs 31

-13%

Q4.23

arrow
arrow

20

20
vs 27

-26%

Q1.24

arrow
arrow

20

20
vs 20

NA

Q2.24

arrow
arrow

2

2
vs 20

-90%

Q3.24

arrow
arrow

1

1
vs 2

-50%

Earnings Growth

Latest News